"Dr Ang Peng Tiam is a Medical Director and Senior Consultant, Medical Oncologist at Parkway Cancer Centre. He is experienced in managing a wide range of cancers including lung cancer, breast cancer, gastrointestinal cancer, genitourinary cancer and malignant lymphoma.

Dr Ang graduated from the National University of Singapore (NUS) with Bachelor in Medicine and Surgery in 1982. He did his residency in Internal Medicine and was conferred the Master of Medicine (Internal Medicine) in 1986. He completed his Fellowship in Medical Oncology at MD Anderson Cancer Centre, Houston, Texas and Stanford University Medical Centre in 1989.

Dr Ang was founding Head of the Department of Medical Oncology at Singapore General Hospital from 1991 to 1997. He held the concurrent post of Director of the Oncology Centre and Clinical Associate Professor at the Faculty of Medicine, NUS.

Dr Ang Peng Tiam has been in private practice since 1997. He leads the team of more than 15 senior consultants and consultants in medical oncology, haematology and palliative medicine to provide care for cancer patients.

Dr Ang Peng Tiam was awarded Singapore President’s scholarship in 1977. He was awarded the Prof Sir Gordon Arthur Ransome Gold medal for being the top candidate in the Master of Medicine Clinical Examinations in 1986, and Singapore’s National Science Award in 1996 for his outstanding contributions in Medical Research. In recognition of his public service, the Sultan of Kedah conferred upon him a datukship in 2003.

Dr Ang is a council member of Singapore Cancer Society. He was also the past President of Singapore Society of Oncology."

"Dr Richard Quek is a Senior Consultant, Medical Oncologist at Parkway Cancer Centre. He is well versed in general medical oncology and his subspecialty interests are in the management of sarcomas, gastrointestinal stromal tumours (GIST), melanomas and lymphomas.

He graduated from the National University of Singapore (NUS) in 1997. He received his internal medicine and medical oncology training at the Singapore General Hospital and National Cancer Centre Singapore (NCCS). In 2008, he was awarded the Singapore Government HMDP fellowship to pursue advanced training and research in the field of soft tissue and bone sarcoma at the Dana-Farber/ Harvard Cancer Centre, Boston, USA. And in 2009, he was awarded the National Medical Research Council (NMRC) fellowship to further his research work in USA.

Prior to joining Parkway Cancer Centre, he was the Deputy Head, Division of Medical Oncology at the NCCS from 2013 – 2018. During this period he also served as the Program Director of the Singhealth Medical Oncology Senior Residency Program.

Dr Quek founded the Singapore Sarcoma Consortium in 2013 and serves as the co-chair for the annual Singapore Sarcoma Symposium. He also founded the Asian Sarcoma Consortium (ASC) in 2015 and continues to lead the ASC whose main aims are to develop sarcoma research and education across Asia.

He has received numerous awards including Service Excellence Awards in 2004 and 2005 and the Singhealth Outstanding Educator Awards in 2013 and 2015. He has published more than 70 papers in peer-reviewed journals and continues to be actively involved in research and education."

Dr. Teo Cheng Peng is a Senior Consultant, Haematologist at Parkway Cancer Centre. He specialises in Blood Cancers, Stem Cell Transplants and in treating patients using the Chimeric Antigen Receptor (CAR) T-cell Therapy.

Dr Teo was awarded the Public Service Commission (PSC) scholarship to study medicine in the Faculty of Medicine, National University of Singapore in 1979. After completing his housemanship training, he passed his post-grad examinations within a short period of 2 years and began his basic training in haematology. He obtained another scholarship from the National University Hospital (NUH) for advanced training in Stem Cell Transplant and Haematological Malignancies at the prestigious Royal Marsden Hospital (United Kingdom).

Upon his return, he started the Stem Cell Transplant service in NUH. This had involved training the nursing team and creating an apheresis unit as well as a stem cell processing and storage unit. He was then recruited to the Department of Medical Oncology, Singapore General Hospital (SGH) to start the Autologous Stem Cell Transplant program for solid tumours. After successfully developing the Stem Cell Transplant program in SGH, he started his medical practice in Gleneagles Hospital and Mount Alvernia Hospital. He brought his expertise in Stem Cell Transplant to the private sector and started the first Stem Cell Transplant in Gleneagles Hospital. He also served in the Blood Transfusion Committees of both Gleneagles Hospital and Mount Alvernia Hospital.

He continued to pursue his interest in the field of stem cell biology and co-founded StemCord, the first private cord blood and stem cell bank in Singapore. This eventually led to the creation of StemMed, which specialises in Mesenchymal Stem Cells production and clinical trials in Regenerative Therapy. Dr Teo continues to be active in his clinical practice and is a founding member of Parkway Cancer Centre and TalkMed.

Dr Dawn Mya is a Senior Consultant, Haematologist at Parkway Cancer Centre. Her area of expertise is in Haematology such as acute leukaemia, lymphoma, multiple myeloma and other general blood diseases such as the disorders of thrombosis and haemostasis, obstetric haematology, anaemia, thrombocytopaenia and other chronic myeloid and lymphoid disorders. Dr Dawn is also qualified in treating patients using the Chimeric Antigen Receptor (CAR) T-cell Therapy.

Dr Dawn Mya completed her Basic Specialist Training in Medicine and Advanced Specialist Training in Haematology at Singapore General Hospital (SGH). She was accredited as a Specialist for Haematology in 2013. She is also a Fellow of the Royal College of Pathologists (Haematology), United Kingdom, since 2014. She received the Ministry of Health, Health Manpower Development Programme award in 2014 and did her subspecialty training in the use of Flow Cytometry for diagnosis and minimal residual disease assessment of haematological cancers at the Department of Haematology and Department of Flow Cytometry Services, University of Salamanca, Spain.

Dr Dawn Mya was previously a Consultant in the Department of Haematology, SGH, where she is now a Visiting Consultant overseeing the Flow Cytometry Services for haematological cancers. She later moved into private practice as a Consultant Haematologist in 2017 where she practised Clinical Haematology as well as headed clinical trials for Lymphoma and Myeloproliferative Disorders as a Principal Investigator.

Dr Dawn was an Adjunct Assistant Professor at the Duke-NUS Graduate Medical School and Senior Clinical Lecturer at Yong Loo Lin School of Medicine. She obtained the Singhealth EPIC award in 2013 for leading the team which successfully implemented a new blood transfusion workflow to improve the clinical management of patients with blood disorders. She received the Singhealth Service Quality Partner Award in 2011, Singhealth Quality Service Award (Gold) in 2014 and Singhealth Quality Service Award (Star) 2015.

She believes that healing patients with blood disorders is a holistic skill that goes beyond science.